Natus Medical (BABY) Misses Q3 EPS by 2c, Offers Q4 Guidance

Natus Medical (NASDAQ: BABY) reported Q3 EPS of $0.40, $0.02 worse than the analyst estimate of $0.42. Revenue for the quarter came in at $130.6 million versus the consensus estimate of $132.92 million.

GUIDANCE:

Natus Medical sees Q4 2018 EPS of $0.48-$0.51, versus the consensus of $0.54. Natus Medical sees Q4 2018 revenue of $135-140 million, versus the consensus of $138.04 million.

For earnings history and earnings-related data on Natus Medical (BABY) click here.

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Boston Omaha Corporation (BOC) Misses Q2 EPS by 2c
• LogicBio Therapeutics (LOGC) Misses Q2 EPS by 10c